StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ZR2.BO$140.00-2.78%
Fair $140.00+0.0%

ZR2.BO

ZR2 Bioenergy Limited

Basic Materials / ChemicalsBSE

$140.00

-4.00 (-2.78%)

Fairly Valued+0.0%Fair Value $140.00Fund rank 19/100 · Data gapFallback financials|
SA 19/F
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-201.9M · quality 28.7/100

Data gap 19/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 1/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

19/100

F

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 0.1%, below the 5% threshold
Thesis & Journal · ZR2.BOLocal privado en este navegador · ZR2 Bioenergy Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$500M

P/E

518.5x

↑

EV/EBITDA

2308.3x

↑

ROE

0.1%

↑

Gross Margin

16.0%

↓

Debt/Equity

N/A

•
52-Week Range$140
$90$437

TradingView lightweight chart

ZR2.BO price, volumen y niveles de valoración

Último $140.00Periodo -67.0%
Fair value: $140.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.0%

FCF CAGR

—

FCF margin

-5917.7%

FCF / Net income

-980.49x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $14.9M · net income $902000.0 · FCF $-884.4M

2022-FY → 2025-FY

Gross margin

16.0%-6.2% pts

Operating margin

-21.5%-25.4% pts

Net margin

6.0%-27.9% pts

FCF margin

-5917.7%-5996.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$14.9M$14.9M$15.7M—$11.6M
Net Income$902000.00$902000.00$3.9M$358120.00$3.9M
EBITDA$2.5M$2.5M$5.8M$482920.00$3.2M
EPS0.020.021.240.2224.22
Gross Margin16.0%16.0%16.0%—22.1%
Operating Margin-21.5%-21.5%7.3%—3.9%
Net Margin6.0%6.0%24.7%—33.9%
Balance Sheet
Debt/Equity——1.312.75—
Cash Flow
Free Cash Flow$-884.4M$-884.4M$-201.9M$-113.4M$9.1M
Returns
ROE0.1%0.1%2.3%0.8%9.0%
Valuation
P/E518.52518.52———
EV/EBITDA2308.272308.27———
P/B4.204.20———
Growth & Yield
Revenue Growth-5.0%-5.0%———
EPS Growth-98.4%-98.4%463.6%-99.1%—
Dividend Yield0.1%0.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

753.2%

muy exigente

EPS terminal req.

$12.42

Spread vs growth

-851.6%

5Y implied EPS CAGR

276.0%

muy exigente

EPS terminal req.

$15.03

Spread vs growth

-374.4%

10Y implied EPS CAGR

103.4%

muy exigente

EPS terminal req.

$24.21

Spread vs growth

-201.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -62.2%

Total return

-62.2%

Start / end P/E

299.2x → 7000.0x

EPS bridge

1.24 → 0.02

Residual

-2203.8%

EPS growth-98.4%
Multiple rerating+2239.9%
Dividend+0.1%
Residual / FX / buybacks / cross-term-2203.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.